Startups
2019
1-10 Employees
OptoGenTech GmbHOptoGenTech GmbH is a biotechnology and medical technology company based in Göttingen, Germany, developing next-generation optogenetic therapies to restore sensory and neurological function.
The company’s lead program is an Optical Cochlear Implant System (OCIS) designed to restore more natural hearing in people with severe-to-profound hearing loss. The system combines a targeted gene therapy that renders auditory neurons light-sensitive with a highly innovative multichannel optical cochlear implant. By using light instead of electrical current for neural stimulation, the technology aims to achieve substantially higher spatial resolution, enabling improved speech understanding in noisy environments, better music perception, and more natural sound quality.
Building on its expertise in gene delivery, engineered opsins, and implantable precision light delivery, OptoGenTech is developing a broader platform for optogenetic therapies and next-generation neural interfaces.
Founded in 2019 as a spin-off from leading academic research in optogenetic hearing restoration, OptoGenTech works closely with academic, clinical, and industry partners to translate optogenetics from research into clinical therapies.
The company’s lead program is an Optical Cochlear Implant System (OCIS) designed to restore more natural hearing in people with severe-to-profound hearing loss. The system combines a targeted gene therapy that renders auditory neurons light-sensitive with a highly innovative multichannel optical cochlear implant. By using light instead of electrical current for neural stimulation, the technology aims to achieve substantially higher spatial resolution, enabling improved speech understanding in noisy environments, better music perception, and more natural sound quality.
Building on its expertise in gene delivery, engineered opsins, and implantable precision light delivery, OptoGenTech is developing a broader platform for optogenetic therapies and next-generation neural interfaces.
Founded in 2019 as a spin-off from leading academic research in optogenetic hearing restoration, OptoGenTech works closely with academic, clinical, and industry partners to translate optogenetics from research into clinical therapies.
Address
Friedrichstraße 3-4, 37073 Göttingen, Germany
Commercial Register
GmbH
HRB 205610
Finance Data
| Date | Investors | Amount | Stage |
Financial Overview
No revenue recorded yet
Seed